May Mabro
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 35
- Cancer Treatment and Pharmacology 22
- Colorectal Cancer Surgical Treatments 4
-
- Gastric Cancer Management and Outcomes 16
- Lung Cancer Treatments and Mutations 9
- Brain Metastases and Treatment 4
- Cancer Research top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
May Mabro
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 77
- Hepatology 403
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 520
- Pathology and Forensic Medicine 254
- Cancer Research 202
Countries citing papers authored by May Mabro
This map shows the geographic impact of May Mabro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Mabro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Mabro more than expected).
Fields of papers citing papers by May Mabro
This network shows the impact of papers produced by May Mabro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Mabro. The network helps show where May Mabro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside May Mabro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 13 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 71 | |
| 6 | 2017 | 9 | |
| 7 | 2013 | 6 | |
| 8 | 2012 | 69 | |
| 9 | 2009 | 262 | |
| 10 | 2009 | 32 | |
| 11 | 2006 | 38 | |
| 12 | 2006 | 24 | |
| 13 | 2006 | 35 | |
| 14 | 2004 | 70 | |
| 15 | 2003 | 19 | |
| 16 | 2000 | 101 | |
| 17 | 1999 | 10 | |
| 18 | 1999 | 30 | |
| 19 | 1999 | 222 | |
| 20 | [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron]. | 1999 | 6 |
About May Mabro
May Mabro is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Gastroenterology and Cancer Research, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Treatment and Pharmacology (22 papers), Gastric Cancer Management and Outcomes (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Lung Cancer Treatments and Mutations (9 papers), Brain Metastases and Treatment (4 papers), Colorectal Cancer Surgical Treatments (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Hepatology (403 citations), Oncology (1.3k citations), Pulmonary and Respiratory Medicine (520 citations), Pathology and Forensic Medicine (254 citations) and Cancer Research (202 citations). May Mabro has collaborated with scholars based in France, Austria and Canada. Frequent co-authors include Thierry André, Aimery de Gramont, Christophe Louvet, Élisabeth Carola, Pascal Artru, F. Maindrault-Gœbel, Christophe Tournigand, M Krulik, Gérard Lledo and Laurent Mineur. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Investigation and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.